March 16 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* AS OF DECEMBER 31, 2022, CABALETTA HAD CASH, CASH
EQUIVALENTS
AND INVESTMENTS OF $106.5 MILLION
* EXPECTS TCASH, CASH EQUIVALENTS & INVESTMENTS AS OF DEC
31,
2022, WILL ENABLE IT TO FUND ITS OPERATING PLAN INTO Q1 OF 2025
* EXPECTING IND CLEARANCE IN FIRST HALF OF 2023 FOR CABA-201
* QTRLY NET LOSS PER SHARE $0.52
* Q4 EARNINGS PER SHARE VIEW $-0.45 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbfqCZC
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;;))